Esperion Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Esperion Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Esperion Therapeutics Inc.
Rating: 1.89008325
Author: Trendlyne DVM scores

about

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the bus...

2.18 -0.01 (-0.46%)

44.67% Fall from 52W High

4.3M

XNAS Volume

XNAS 27 Aug, 2025 4:18 PM (EDT)

Not Eligible

Expensive Valuation

13.8 / 100

Technically Moderately Bullish

61.8 / 100

1Yr Price target upside is 166%

7 analysts

Esperion Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Esperion Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the bus...

44.67% Fall from 52W High

SWOT Analysis

Esperion Therapeutics Inc. Live Price Chart